AWL Agri Busine. (AWL)
CyclicalFairStock Score: 74/100 — STEADY
Score breakdown: P/E: 1/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹192.16 |
| Market Cap | ₹24,823.57 Cr |
| P/E Ratio | 21.49 |
| ROCE | 20.89% |
| ROE | 9.98% |
| Dividend Yield | 0.52% |
| Profit Growth | 47.3% |
| Debt/Equity | 0.11 |
| Sales Growth | 17.5% |
| Free Cash Flow | ₹1,872 Cr |
| Promoter Holding | 56.94% |
| 52-Week Range | ₹171.19 — ₹282.9 |
| Sector | Agricultural Food & other Products |
| Book Value | ₹80.73 |
Strengths
- Large scale with quarterly sales of ₹18,603 Cr provides distribution and brand advantages
- Strong balance sheet with debt/equity of 0.11 and Altman Z-Score of 4.56
- Healthy free cash flow of ₹1,872 Cr despite profit decline
- Promoter holding of 56.94% aligns management with minority shareholders
- Five-year revenue CAGR of 11.41% shows franchise expansion
Concerns
- Profit growth of -21.09% while sales grew 21.85% indicates margin compression
- Extremely thin net margin: ₹269 Cr net profit on ₹18,603 Cr quarterly sales is roughly 1.4%
- Valuation is rich: P/E of 25.63, price above Graham Number of ₹108.61, and DCF intrinsic value of ₹25.28
- Zero dividend yield gives shareholders no cash return while waiting for growth
AI Analysis
I start by asking whether the business has durable economics. AWL sells edible oil, a daily necessity, but the latest quarter makes the model clear: ₹18,603 Cr of revenue produced only ₹269 Cr of net profit. That is a net margin below 1.5%. No amount of scale can fully protect you when the raw material is a global commodity and you are largely a price-taker. Revenue has compounded at 11.4% over five years, and latest sales grew 21.85%, yet profit fell 21.09%. That divergence is exactly what worries me: growth is buying turnover, not earnings power. The balance sheet is decent: debt/equity of 0.11, Altman Z-Score of 4.56, Piotroski F-Score of 7/9, and free cash flow of ₹1,872 Cr. Promoters own 56.94%, so there is skin in the game. ROCE of 20.89% is respectable, but the equity return is lower at 9.98%, suggesting the franchise cannot command a high margin on capital. Now valuation. I refuse to pay 25.63 times earnings for a business whose earnings are falling. Graham's Number, ₹108.61, is far below the current price of ₹197.30, and the DCF intrinsic value of ₹25.28 is even lower. There is no margin of safety. The zero dividend compounds the problem: I get no cash while I wait. This is not a terrible company; it is a cyclical, low-margin, financially solid business. But at this price, I am being asked to pay for growth that is not showing up in profits. I would wait for either margins to recover or the share price to provide a Graham-style margin of safety.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer